257 related articles for article (PubMed ID: 27606941)
1. A Newly Defined and Xeno-Free Culture Medium Supports Every-Other-Day Medium Replacement in the Generation and Long-Term Cultivation of Human Pluripotent Stem Cells.
Ahmadian Baghbaderani B; Tian X; Scotty Cadet J; Shah K; Walde A; Tran H; Kovarcik DP; Clarke D; Fellner T
PLoS One; 2016; 11(9):e0161229. PubMed ID: 27606941
[TBL] [Abstract][Full Text] [Related]
2. Synergistic effect of medium, matrix, and exogenous factors on the adhesion and growth of human pluripotent stem cells under defined, xeno-free conditions.
Meng G; Liu S; Rancourt DE
Stem Cells Dev; 2012 Jul; 21(11):2036-48. PubMed ID: 22149941
[TBL] [Abstract][Full Text] [Related]
3. Culture conditions affect cardiac differentiation potential of human pluripotent stem cells.
Ojala M; Rajala K; Pekkanen-Mattila M; Miettinen M; Huhtala H; Aalto-Setälä K
PLoS One; 2012; 7(10):e48659. PubMed ID: 23119085
[TBL] [Abstract][Full Text] [Related]
4. Controlled Growth and the Maintenance of Human Pluripotent Stem Cells by Cultivation with Defined Medium on Extracellular Matrix-Coated Micropatterned Dishes.
Takenaka C; Miyajima H; Yoda Y; Imazato H; Yamamoto T; Gomi S; Ohshima Y; Kagawa K; Sasaki T; Kawamata S
PLoS One; 2015; 10(6):e0129855. PubMed ID: 26115194
[TBL] [Abstract][Full Text] [Related]
5. Facile engineering of xeno-free microcarriers for the scalable cultivation of human pluripotent stem cells in stirred suspension.
Fan Y; Hsiung M; Cheng C; Tzanakakis ES
Tissue Eng Part A; 2014 Feb; 20(3-4):588-99. PubMed ID: 24098972
[TBL] [Abstract][Full Text] [Related]
6. Xeno- and feeder-free differentiation of human pluripotent stem cells to two distinct ocular epithelial cell types using simple modifications of one method.
Hongisto H; Ilmarinen T; Vattulainen M; Mikhailova A; Skottman H
Stem Cell Res Ther; 2017 Dec; 8(1):291. PubMed ID: 29284513
[TBL] [Abstract][Full Text] [Related]
7. Efficient Expansion of Dissociated Human Pluripotent Stem Cells Using a Synthetic Substrate.
Kawase E
Methods Mol Biol; 2016; 1307():61-9. PubMed ID: 24875248
[TBL] [Abstract][Full Text] [Related]
8. Production of human pluripotent stem cell therapeutics under defined xeno-free conditions: progress and challenges.
Fan Y; Wu J; Ashok P; Hsiung M; Tzanakakis ES
Stem Cell Rev Rep; 2015 Feb; 11(1):96-109. PubMed ID: 25077810
[TBL] [Abstract][Full Text] [Related]
9. Robust protocol for feeder-free adaptation of cryopreserved human pluripotent stem cells.
Aalders J; Van den Vreken N; Popovic M; Mishra S; Heindryckx B; van Hengel J
In Vitro Cell Dev Biol Anim; 2019 Dec; 55(10):777-783. PubMed ID: 31664691
[TBL] [Abstract][Full Text] [Related]
10. Xeno-free culture of human pluripotent stem cells.
Bergström R; Ström S; Holm F; Feki A; Hovatta O
Methods Mol Biol; 2011; 767():125-36. PubMed ID: 21822871
[TBL] [Abstract][Full Text] [Related]
11. Chemically defined and growth-factor-free culture system for the expansion and derivation of human pluripotent stem cells.
Yasuda SY; Ikeda T; Shahsavarani H; Yoshida N; Nayer B; Hino M; Vartak-Sharma N; Suemori H; Hasegawa K
Nat Biomed Eng; 2018 Mar; 2(3):173-182. PubMed ID: 31015717
[TBL] [Abstract][Full Text] [Related]
12. Feeder-free and xeno-free culture of human pluripotent stem cells using UCBS matrix.
Ding Y; Yang H; Yu L; Xu CL; Zeng Y; Qiu Y; Li DS
Cell Biol Int; 2015 Oct; 39(10):1111-9. PubMed ID: 25939663
[TBL] [Abstract][Full Text] [Related]
13. Impact of Feeding Strategies on the Scalable Expansion of Human Pluripotent Stem Cells in Single-Use Stirred Tank Bioreactors.
Kropp C; Kempf H; Halloin C; Robles-Diaz D; Franke A; Scheper T; Kinast K; Knorpp T; Joos TO; Haverich A; Martin U; Zweigerdt R; Olmer R
Stem Cells Transl Med; 2016 Oct; 5(10):1289-1301. PubMed ID: 27369897
[TBL] [Abstract][Full Text] [Related]
14. Suspended in culture--human pluripotent cells for scalable technologies.
O'Brien C; Laslett AL
Stem Cell Res; 2012 Sep; 9(2):167-70. PubMed ID: 22771716
[TBL] [Abstract][Full Text] [Related]
15. Growth of Human Pluripotent Stem Cells Using Functional Human Extracellular Matrix.
Sanz-Garcia A; Stojkovic M; Escobedo-Lucea C
Methods Mol Biol; 2016; 1307():39-60. PubMed ID: 25476443
[TBL] [Abstract][Full Text] [Related]
16. Stable propagation of human embryonic and induced pluripotent stem cells on decellularized human substrates.
Abraham S; Sheridan SD; Miller B; Rao RR
Biotechnol Prog; 2010; 26(4):1126-34. PubMed ID: 20730767
[TBL] [Abstract][Full Text] [Related]
17. Chemical-defined and albumin-free generation of human atrial and ventricular myocytes from human pluripotent stem cells.
Pei F; Jiang J; Bai S; Cao H; Tian L; Zhao Y; Yang C; Dong H; Ma Y
Stem Cell Res; 2017 Mar; 19():94-103. PubMed ID: 28110125
[TBL] [Abstract][Full Text] [Related]
18. Dosage and cell line dependent inhibitory effect of bFGF supplement in human pluripotent stem cell culture on inactivated human mesenchymal stem cells.
Quang T; Marquez M; Blanco G; Zhao Y
PLoS One; 2014; 9(1):e86031. PubMed ID: 24465853
[TBL] [Abstract][Full Text] [Related]
19. Human Pluripotent Stem Cell Expansion in Stirred Tank Bioreactors.
Manstein F; Halloin C; Zweigerdt R
Methods Mol Biol; 2019; 1994():79-91. PubMed ID: 31124106
[TBL] [Abstract][Full Text] [Related]
20. Long-term xeno-free culture of human pluripotent stem cells on hydrogels with optimal elasticity.
Higuchi A; Kao SH; Ling QD; Chen YM; Li HF; Alarfaj AA; Munusamy MA; Murugan K; Chang SC; Lee HC; Hsu ST; Kumar SS; Umezawa A
Sci Rep; 2015 Dec; 5():18136. PubMed ID: 26656754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
